Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MY008211A in adult PNH patients with active hemolysis
NCT06134414Phase 2Not yet recruiting
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd.
- Start
- Dec 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MY-008 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Wuhan Createrna Science and Technology Co., Ltd.. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
MY-008
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT06134414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06134414.